BIOTINDERIVATE

European patent · EP2633062 · In force

Register entry

Publication number
EP2633062
Application number
EP11837225
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 28, 2011
Published
Sep 4, 2013
Granted
Dec 27, 2017
Protection ends at the latest
Oct 27, 2031
Next annual fee due
Oct 31, 2026
IPC classes
G01N 33/532 (2006.01)
G01N 33/543 (2006.01)
C07D 495/04 (2006.01)
C08B 37/00 (2006.01)
G01N 33/58 (2006.01)
Priority
US 201161510949 P 22.07.2011
US 201161501500 P 27.06.2011
US 201161495070 P 09.06.2011
US 408210 P 29.10.2010
PCT application
PCT/US2011/058455 28.10.2011
PCT publication
WO2012/058635 03.05.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Dec 27, 2017

    Granted

    Published in Swissreg on 27.12.2017

Parties

Holder

Life Technologies Corporation

5823 Newton Drive, Carlsbad, CA 92008, US

Inventor

YING, Lai-Qiang

Eugene Oregon 97402, US

YUE, Stephen

Eugene Oregon 97405, US

BRANCHAUD, Bruce

Eugene Oregon 97405, US

ZHANG, Yu-Zhong

Eugene Oregon 97405, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.